Managers / Q3 2020 · view latest →
Global Frontier Investments LLC
CIK 0001821219 · 92 BROAD STREET, CHARLESTON, SC, 29401 · 4154020285
Summary
Global Frontier Investments LLC reported $68M in U.S.-listed holdings across 17 positions for Q3 2020.
The portfolio is heavily concentrated: JPM alone accounts for 34.8% of reported value.
Compared with Q2 2020, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 93.0% · $63M
- Other · 7.0% · $5M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| AMRYT PHARMA LTD - SPNR ADR | NEW | +125.0K | 125.0K | +$2M | $2M |
| WALWESTERN ALLIANCE BANCORP | HELD | +0 | 120.0K | −$750,000 | $4M |
| PGRPROGRESSIVE CORP | HELD | +0 | 45.0K | +$655,000 | $4M |
| JPMJPMORGAN CHASE | HELD | +0 | 245.0K | +$541,000 | $24M |
| BRK/ABERKSHIRE HATHAWAY INC CL A | HELD | +0 | 10 | +$527,000 | $3M |
| CCITIGROUP INC | HELD | +0 | 50.0K | −$399,000 | $2M |
| OXFORD IMMUNOTEC GLOBAL PLC | HELD | +0 | 272.3K | −$353,000 | $3M |
| KKRKKR | HELD | +0 | 100.0K | +$346,000 | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | JPMJPMORGAN CHASEhistory → | COMMON EQUITY | 34.80% | $24M | 245.0K |
| 2 | PGRPROGRESSIVE CORPhistory → | COMMON EQUITY | 6.29% | $4M | 45.0K |
| 3 | WALWESTERN ALLIANCE BANCORPhistory → | COMMON EQUITY | 5.60% | $4M | 120.0K |
| 4 | KKRKKRhistory → | COMMON EQUITY | 5.07% | $3M | 100.0K |
| 5 | ACNACCENTURE PLC CL Ahistory → | COMMON EQUITY | 5.00% | $3M | 15.0K |
| 6 | BRK/ABERKSHIRE HATHAWAY INC CL Ahistory → | COMMON EQUITY | 4.72% | $3M | 10 |
| 7 | OXFORD IMMUNOTEC GLOBAL PLC | COMMON EQUITY | 4.70% | $3M | 272.3K |
| 8 | AONAON PLC CLASS Ahistory → | COMMON EQUITY | 4.57% | $3M | 15.0K |
| 9 | GSGOLDMAN SACHS GROUP INChistory → | COMMON EQUITY | 4.45% | $3M | 15.0K |
| 10 | OZKBANK OZKhistory → | COMMON EQUITY | 3.93% | $3M | 125.0K |
| 11 | AXPAMERICAN EXPRESS COhistory → | COMMON EQUITY | 3.70% | $3M | 25.0K |
| 12 | NTRSNORTHERN TRUST CORPhistory → | COMMON EQUITY | 3.45% | $2M | 30.0K |
| 13 | CCITIGROUP INChistory → | COMMON EQUITY | 3.18% | $2M | 50.0K |
| 14 | CADENCE BANCORP | COMMON EQUITY | 3.17% | $2M | 250.0K |
| 15 | SCHWSCHWAB (CHARLES) CORPhistory → | COMMON EQUITY | 2.67% | $2M | 50.0K |
| 16 | WFCWELLS FARGOhistory → | COMMON EQUITY | 2.43% | $2M | 70.0K |
| 17 | AMRYT PHARMA LTD - SPNR ADR | COMMON EQUITY | 2.28% | $2M | 125.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026REVEALED | $1.2B | 53 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $507M | 23 | Feb 18, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $519M | 23 | Nov 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $419M | 23 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $389M | 23 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $335M | 23 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $341M | 23 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $231M | 23 | Dec 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $228M | 23 | Aug 16, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $223M | 23 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $227M | 23 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $197M | 23 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $215M | 23 | Aug 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $259M | 23 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $265M | 22 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $137M | 19 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $132M | 18 | Aug 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $116M | 18 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $103M | 18 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $68M | 17 | Nov 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $66M | 16 | Aug 17, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.